DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epivir (Lamivudine) - Adverse Event Reports - Hospitalization - Dyspnoea

 



Index of reports > Cases resulting in hospitalization (92) > Cases with Dyspnoea (7)

Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in hospitalization where reactions include dyspnoea.

Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Stocrin Caps
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Epivir
    Dosage: interrupted on 17-apr-2006 restarted on 18-apr-2006 at 300mg daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Abacavir Sulfate



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-07-24

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Simavastatin



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-04-23

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-04-18

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Takepron; Pentamidine Isethionate; Lipovas



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-04-16

Patient: 65 year old female

Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Zerit
    Dosage: 60mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30
    End date: 2006-04-17

Stocrin
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-09-30

Ziagen
    Dosage: 300mg twice per day
    Administration route: Oral
    Indication: HIV Infection

Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Takepron; Pentamidine Isethionate; Lipovas



Adverse event in 42 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-03-14

Patient: 42 year old male

Adverse reactions / side effects: Blood Methaemoglobin Present, Dyspnoea, Cytolytic Hepatitis, Cholestasis, Lactic Acidosis, Hepatitis, Hyperlipidaemia, Pancreatitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Fuzeon
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2003-09-15
    End date: 2006-12-19

TMC 114
    Dosage: dosage: 4 doses per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-01-31
    End date: 2006-12-19

Azadose
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    End date: 2006-12-19

Epivir
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2003-09-15
    End date: 2006-12-19

Norvir
    Dosage: drug: norvir 100. dosage: 2 doses per day
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2003-09-15
    End date: 2006-12-19

Videx
    Dosage: drug: videx 400.
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-01-31
    End date: 2006-12-19

Other drugs received by patient: Lasix; Cortancyl; Valacyclovir HCL; Lyrica; Tramadol HCL; Rivotril



Adverse event in 42 year old male receiving Epivir (Lamivudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-02-26

Patient: 42 year old male

Adverse reactions / side effects: Dyspnoea, Cytolytic Hepatitis, Cholestasis, Lactic Acidosis, Hepatitis, Ocular Icterus, Pancreatitis, Lipase Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Videx EC
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-31
    End date: 2006-12-19

Norvir
    Administration route: Oral
    Start date: 2003-09-15
    End date: 2006-12-19

Epivir
    Administration route: Oral
    Start date: 2003-09-15
    End date: 2006-12-19

Fuzeon
    Administration route: Oral
    Start date: 2003-09-15
    End date: 2006-12-19

Azadose
    Administration route: Oral
    End date: 2006-12-19

Darunavir
    Administration route: Oral
    Start date: 2006-01-31
    End date: 2006-12-19

Other drugs received by patient: Lasix; Cortancyl; Valacyclovir HCL; Lyrica; Tramadol HCL; Rivotril



Adverse event in 42 year old male receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from France on 2007-02-20

Patient: 42 year old male

Adverse reactions / side effects: Dyspnoea, Cytolytic Hepatitis, Cholestasis, Lactic Acidosis, Hepatitis, Ocular Icterus, Pancreatitis, Lipase Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-15
    End date: 2006-12-19

Combivir
    Indication: HIV Infection
    Start date: 2003-05-01
    End date: 2003-09-15

Norvir
    Dosage: 2unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-15
    End date: 2006-12-19

Videx
    Dosage: 400mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-31
    End date: 2006-12-19

Fuzeon
    Dosage: 1.8g per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2003-09-15
    End date: 2006-12-19

Azadose
    Dosage: 1.2g weekly
    Administration route: Oral
    End date: 2006-12-19

Darunavir
    Dosage: 4unit per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-31
    End date: 2006-12-19

Other drugs received by patient: Valacyclovir HCL; Lasix; Cortancyl; Lyrica; Topalgic ( France ); Rivotril

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009